Status™ Flu A&B Rapid Test: Fast and Accurate Influenza Detection

The Status™ Flu A&B Rapid Test is a visually read, rapid in vitro diagnostic test that detects and differentiates Influenza A and Influenza B viral antigens in 10 to 15 minutes. Designed for professional point-of-care use, this CLIA-waived test helps healthcare providers diagnose flu infections quickly, allowing for faster clinical decisions and timely patient care.



Key Features

  • Detects Influenza A and Influenza B

  • Results in 10–15 minutes

  • CLIA Waived for professional point-of-care testing

  • Easy visual interpretation

  • Uses nasal swab, nasopharyngeal swab, or nasal wash/aspirate specimens

  • Simple testing procedure with premeasured reagent capsules

  • Suitable for hospitals, clinics, physician offices, and urgent care centers

How the Status™ Flu A&B Test Works

The testing process is simple and designed for busy healthcare settings.

Step 1: Collect the Sample

Collect a specimen using the provided flocked swab or an approved nasal wash/aspirate sample. The flocked swab helps improve sample collection while providing greater patient comfort.

Step 2: Prepare the Sample

Place the collected swab into the premeasured reagent capsule and mix according to the test instructions to extract the viral antigens.



Step 3: Apply the Sample

Add the recommended number of drops from the prepared sample into the sample well of the test device.

Step 4: Read the Results

Wait 10 to 15 minutes before reading the results.

  • Positive for Influenza A: Colored lines appear at the Control (C) line and Influenza A (A) line.

  • Positive for Influenza B: Colored lines appear at the Control (C) line and Influenza B (B) line.

  • Negative Result: Only the Control (C) line appears.

  • Invalid Result: If the Control (C) line does not appear, the test is invalid and should be repeated.

Benefits of the Status™ Flu A&B Test

Healthcare professionals choose the Status™ Flu A&B Rapid Test because it offers:

  • Rapid results in 10–15 minutes

  • High-quality point-of-care testing

  • Simple and easy-to-follow procedure

  • Reliable influenza detection

  • Easy visual interpretation

  • Efficient workflow for busy healthcare environments

Ideal for Healthcare Settings

The Status™ Flu A&B Rapid Test is commonly used in:

  • Hospitals

  • Physician offices

  • Urgent care centers

  • Community health clinics

  • Diagnostic laboratories

  • Other CLIA-waived healthcare facilities

Its fast turnaround time helps healthcare providers make informed treatment decisions during flu season.

Buy the Status™ Flu A&B Test from RCS Healthcare

At RCS Healthcare, we are committed to providing trusted diagnostic products at reasonable prices. The Status™ Flu A&B Rapid Test is available for only $175.00, offering an affordable solution for hospitals, clinics, physician offices, and laboratories looking for dependable influenza testing.

When you purchase from RCS Healthcare, you benefit from:

  • Competitive price of just $175.00

  • High-quality diagnostic products

  • Fast and reliable order processing

  • Excellent customer support

  • Trusted medical supplies for healthcare professionals

Whether you're stocking your clinic or expanding your point-of-care testing capabilities, RCS Healthcare provides reliable diagnostic solutions at prices that help you manage your budget without compromising on quality.

Final Thoughts

The Status™ Flu A&B Rapid Test is a dependable, easy-to-use diagnostic solution for detecting Influenza A and Influenza B in professional healthcare settings. With rapid results in just 10–15 minutes, a straightforward testing procedure, and reliable performance, it supports faster diagnosis and improved patient care.

For high-quality influenza testing at an affordable price, choose the Status™ Flu A&B Rapid Test from RCS Healthcare, available for only $175.00.

Comments

Popular posts from this blog

Is a Rapid Flu Test Recommended for Mild Flu Symptoms?

What Is a FebriDx Test? How to Use It for Fast Infection Detection

How point-of-care (POC) labs contribute to the prevention of infectious disease?